In this way, Brasbiotec has specialized in the valuation process of biotechnology businesses, mainly associated with companies in the early stages of development, where there are few resources and investments, often with only one product not yet validated in the market, and with high expectations growth and economic gains.

For this, the company developed its own methodology that allows the integration of value vectors, providing a more efficient valuation when compared to traditional valuation methodologies.

 

If you have interest or questions about our methodology and valuation process, please contact us.